FDA panel votes to add peptides to permitted list despite opposition from agency scientists
Headline from MyStateline, on the newest of 2 developments
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
MyStateline's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers
Headline from WHEC Rochester ·
Newest
FDA panel votes to add peptides to permitted list despite opposition from agency scientists
* FDA panel to meet on July 23 and 24 to review seven peptides * Reddit, biohacking forums drive demand for peptides * Several panel voters have ties to peptide businesses By Sneha S K and Sriparna
Peptides are exploding in popularity. From celebrities and influencers to suburban moms and even teens, millions of people are sharing what’s in their peptide “stack” and jumping on the latest health craze.
Federal health advisers are recommending broader access to controversial chemicals called peptides. The unapproved injections have become a popular wellness trend, promoted by influencers and celebrities.
WASHINGTON (AP) — Health advisers begin meeting Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective.
Federal health advisers are meeting to review a group of controversial chemicals called peptides. The unapproved injections have become a popular wellness trend, promoted by influencers and celebrities for building muscle, healing injuries and other uses.
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.
Peptides are often being promoted by wellness influencers and podcasters as treatments for everything from injuries and aging and now an FDA panel is meeting to discuss whether to loosen restrictions and make them easier to get. But critics say there's not enough data on safety and efficacy.
The FDA is convening an advisory committee over the next two days to discuss whether compounding pharmacies can dispense seven unapproved peptides with a doctor's prescription for special medical conditions. Some health experts are skeptical because of the lack of research. Adam Yamaguchi reports.
Health advisers begin meeting Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective.
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
The committee’s decisions could signal whether scientists’ calls for caution still hold sway amid Robert F. Kennedy Jr.’s push to center alternative medicine and patient choice in federal health policy.
An FDA advisory committee began a two-day meeting to consider lifting a ban and widening access to seven popular peptides. They have seen a surge of support from wellness influencers and others, including Health Secretary Robert F. Kennedy Jr. Amna Nawaz discussed more with Dr.
Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government sc…
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists.
An FDA advisory panel recommended easing restrictions on certain peptides on Thursday. Peptides are short chains of amino acids that can help regulate a variety of functions in the body. CBS News correspondent Adam Yamaguchi reports.
A US review panel on Thursday recommended loosening restrictions on multiple trendy peptides, endorsing proposals that specialized pharmacies be allowed to produce such substances despite alarm bells from medical experts over safety concerns.
WASHINGTON -- A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven't been shown safe or effective.
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven’t been shown to be safe or effective.
Showing the first 25 of 26 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA panel votes to add peptides to permitted list despite opposition from agency scientists | Since Then
